Published in Science on December 01, 1967
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med (1984) 10.66
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med (1969) 3.87
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Immunopathology of lymphocytic choriomeningitis viurs infection of newborn mice. Antithymocyte serum effects on glomerulonephritis and wasting disease. J Exp Med (1968) 2.31
Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A (1974) 2.27
Immune therapy of a persistent and disseminated viral infection. J Virol (1987) 2.24
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol (1974) 2.12
Viral infection and renal transplant rejection. Br Med J (1972) 1.87
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis. Am J Pathol (1972) 1.51
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A (2003) 1.41
Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity. Immunology (1981) 1.36
Structural proteins of Pichinde virus. J Virol (1972) 1.33
Chronic allogeneic disease. I. Development of glomerulonephritis. J Exp Med (1968) 1.28
Mechanisms of suppression of cytotoxic T-cell responses in murine lymphocytic choriomeningitis virus infection. J Exp Med (1977) 1.21
T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc Natl Acad Sci U S A (1988) 1.18
Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology (1985) 1.18
Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses (2012) 1.12
Ultrastructural pathology of glomerular lesions in gnotobiotic mice with congenital lymphocytic choriomeningitis (LCM) virus infection. Am J Pathol (1970) 1.05
Persistent infection of the mouse with the virus of lymphocytic choriomeningitis. J Clin Pathol Suppl (R Coll Pathol) (1972) 1.04
Experimental adenovirus immune complex glomerulonephritis. Br J Exp Pathol (1973) 1.04
The activity of T and B lymphocytes in immunity and tolerance to the lymphocytic choriomeningitis virus in mice. Immunology (1975) 1.03
Spontaneous glomerulonephritis in sheep. II. Studies on natural history, occurrence in other species, and pathogenesis. Am J Pathol (1968) 1.03
Evidence for immunologic mechanisms in several forms of human glomerular diseases. Bull N Y Acad Med (1970) 1.01
Failure to detect antibody against Gross virus in tetraparental AKR reversible CBA mouse chimaeras. Br J Cancer (1975) 0.99
Anatomy of viral persistence. PLoS Pathog (2009) 0.96
Proliferative glomerulonephritis in children. A correlation of varied clinical and pathologic patterns utilizing light, immunofluorescence, and electron microscopy. Am J Pathol (1969) 0.95
Naturally occurring immune-complex glomerulonephritis in monkeys (Macaca irus). I. Light, immunofluorescence and electron microscopic studies. Am J Pathol (1974) 0.95
Antigens of Pichinde virus I. Relationship of soluble antigens derived from infected BHK-21 cells to the structural components of the virion. J Virol (1977) 0.92
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza. Proc Natl Acad Sci U S A (2013) 0.91
Autologous immune responses to the major oncornavirus polypeptides in unmanipulated AKR/J mice. J Virol (1976) 0.90
Persistent LCM virus infection in the mouse. Immunity and tolerance. Bull World Health Organ (1975) 0.89
On the induction of immunological tolerance to a self-reproducing antigen. Immunology (1969) 0.89
Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J Virol (1998) 0.87
Immune complex diseases. I. Pathological changes in the kidneys of BALB-c mice neonatally infected with Moloney leukaemogenic and murine sarcoma viruses. Clin Exp Immunol (1971) 0.85
Effect of immunosuppression on chronic LCM virus infection of mice. J Exp Med (1973) 0.83
Susceptibility of newborn mice with H-2k backgrounds to lymphocytic choriomeningitis virus infection. Immunology (1980) 0.82
LCM virus infection of cells in vitro. Bull World Health Organ (1975) 0.80
Lymphocytic choriomeningitis in Michigan. Emerg Infect Dis (2006) 0.80
Nephropathy and viroses. Postgrad Med J (1968) 0.77
Neutralizing antibody response of guinea pigs to lymphocytic choriomeningitis virus. Infect Immun (1974) 0.76
Immunopathology of nephritis in Africa. Bull World Health Organ (1972) 0.75
Molecular mimicry and clonal deletion: A fresh look. J Theor Biol (2014) 0.75
Electrocardiographic pattern in intracranial hemorrhage. Can Med Assoc J (1969) 0.75
Profile of Michael B. A. Oldstone. Interview by Nicholette Zeliadt. Proc Natl Acad Sci U S A (2013) 0.75
Current views on the pathogenesis and etiology of rheumatoid arthritis. Can Med Assoc J (1969) 0.75
Immune responses to virus-induced tumours. Proc R Soc Med (1969) 0.75
Progress with hepatitis B virus-editorial review. West J Med (1978) 0.75
Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web. Yale J Biol Med (1974) 0.75
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med (1984) 10.66
Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol (1980) 6.24
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science (1998) 5.83
Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med (2001) 5.74
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol (1984) 5.57
Molecular mimicry and autoimmune disease. Cell (1987) 5.31
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J Gen Virol (1983) 4.45
Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature (1986) 4.01
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol (1995) 3.90
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol (1978) 3.78
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61
Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med (2000) 3.50
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39
The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27
Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology (1981) 3.26
Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology (1988) 3.22
Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med (1975) 3.13
Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int (1973) 3.09
The biology and detection of immune complexes. Adv Immunol (1979) 3.05
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol (1979) 2.86
Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med (1979) 2.86
Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J Virol (1988) 2.82
Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol (1989) 2.79
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A (1993) 2.79
Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology (1988) 2.76
A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med (1982) 2.76
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol (2000) 2.74
Organ-specific selection of viral variants during chronic infection. J Exp Med (1988) 2.71
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A (1996) 2.68
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology (1995) 2.60
How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity (1994) 2.56
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 2.53
Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science (1991) 2.51
Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51
Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med (1966) 2.42
Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med (1973) 2.39
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J Exp Med (1976) 2.34
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Replication and persistence of measles virus in defined subpopulations of human leukocytes. J Virol (1975) 2.30
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. Virology (1989) 2.25
Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin. Prog Med Virol (1975) 2.23
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med (1996) 2.21
Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol (1976) 2.18
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15
Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology (1990) 2.12
Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Immunohistochemical study of allergic encephalomyelitis. Am J Pathol (1968) 2.10
Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation. J Exp Med (1975) 2.09
Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A (1994) 2.08
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07
Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07
Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med (1980) 2.07
Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med (1983) 2.06
Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway. J Exp Med (1975) 2.06
Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. J Virol (1989) 2.05
Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol (2001) 2.03